deltatrials
Unknown PHASE1 INTERVENTIONAL 1-arm NCT02347228

Evaluate Safety, Tolerability, PK, Preliminary Clinical Activity of OB318 in Patients With Advanced Solid Malignancies

A Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity of OB318 in Patients With Advanced Solid Malignancies

Sponsor: Oneness Biotech Co., Ltd.

Conditions Advanced Solid Malignancies
Interventions OB318 capsule
Updated 12 times since 2017 Last updated: Jan 25, 2024 Started: Sep 11, 2020 Primary completion: Dec 31, 2024 Completion: Dec 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Advanced Solid Malignancies, this trial is ongoing. The trial is conducted by Oneness Biotech Co., Ltd. and has accumulated 12 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotNot Yet Recruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Jan 2020 · 19 months · monthly snapshotNot Yet Recruiting~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshotUnknown Status~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotUnknown Status~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshotRecruiting~Dec 2021 – ~Apr 2023 · 16 months · monthly snapshotRecruiting~Apr 2023 – ~Feb 2024 · 10 months · monthly snapshotRecruiting~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshotRecruiting~Apr 2025 – present · 17 months · monthly snapshotUnknown

Change History

12 versions recorded

  1. Apr 2025 — Present [monthly]

    Unknown PHASE1

    Status: Recruiting → Unknown

  2. Sep 2024 — Apr 2025 [monthly]

    Recruiting PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1

  4. Feb 2024 — Jul 2024 [monthly]

    Recruiting PHASE1

  5. Apr 2023 — Feb 2024 [monthly]

    Recruiting PHASE1

▶ Show 7 earlier versions

  1. Dec 2021 — Apr 2023 [monthly]

    Recruiting PHASE1

  2. Oct 2021 — Dec 2021 [monthly]

    Recruiting PHASE1

    Status: Unknown Status → Recruiting

  3. Jan 2021 — Oct 2021 [monthly]

    Unknown Status PHASE1

  4. Jan 2020 — Jan 2021 [monthly]

    Unknown Status PHASE1

    Status: Not Yet Recruiting → Unknown Status

  5. Jun 2018 — Jan 2020 [monthly]

    Not Yet Recruiting PHASE1

  6. Feb 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE1

  7. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Oneness Biotech Co., Ltd.
Data source: Oneness Biotech Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations